IL18 and cerebral infarction: In summary, our study showed HAX-1 attenuated microglial pyroptosis both in vivo and in vitro and reduced the inflammatory responses in cerebral infarction through inhibition of proinflammatory cytokines such as IL-1 and IL-18.